Please login to the form below

Not currently logged in
Email:
Password:

Bone Therapeutics

This page shows the latest Bone Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Stem cell drug first for Osiris

Stem cell drug first for Osiris. US firm's Prochymal approved in Canada to treat bone marrow transplant complication. ... Canadian regulators have approved a stem cell treatment for acute graft vs host disease (GvHD), a potentially fatal complication of

Latest news

  • BioMimetic bone graft wins panel support

    BioMimetic bone graft wins panel support. A US Food and Drug Administration committee has voted in support of BioMimetic Therapeutics' Augment Bone Graft for use as an alternative to autograft in ... The US Food and Drug Administration's (FDA)

  • Malcolm's Market Eye: 7 to 13 July 2007

    Now a study in US publication Diabetes Care has suggested that Avandia could reduce bone mineral density in men. ... Northwest Therapeutics gets Swiss green light for brain cancer vaccine. Northwest Therapeutics saw its share price rise by 38p to 140p on

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Bone Therapeutics strengthens board with new chairman Bone Therapeutics strengthens board with new chairman

    Bone Therapeutics strengthens board with new chairman. Jean Stéphenne joins the cell therapy company from TiGenix. ... Belgian biotechnology company Bone Therapeutics has appointed Jean Stéphenne as its new chairman of the board of directors,

  • Zelluna appoints Miguel Forte as CEO Zelluna appoints Miguel Forte as CEO

    Zelluna appoints Miguel Forte as CEO. He joins the Norwegian biotech from Bone Therapeutics. ... Prior to his new role, Forte has held roles for Bone Therapeutics, TxCell, the European Medicines Agency, and  UCB to name a few.

  • Bone Therapeutics strengthens clinical development team Bone Therapeutics strengthens clinical development team

    Bone Therapeutics strengthens clinical development team. Dr Miguel Forte joins the firm as chief medical officer. ... Dr Miguel Forte has joined Belgium biotechnology company Bone Therapeutics as its new chief medical officer.

  • Bone Therapeutics looks to Pfizer for clinical head Bone Therapeutics looks to Pfizer for clinical head

    Bone Therapeutics looks to Pfizer for clinical head. Guy Heynen has 35 years of industry experience. ... Bone Therapeutics, the regenerative therapy company for bone diseases and orthopaedics, has named Guy Heynen as its chief clinical and regulatory

  • Bone Therapeutics looks to Pfizer for clinical head Bone Therapeutics looks to Pfizer for clinical head

    Bone Therapeutics looks to Pfizer for clinical head. Guy Heynen has 35 years of industry experience. ... Bone Therapeutics, the regenerative therapy company for bone diseases and orthopaedics, has named Guy Heynen as its chief clinical and regulatory

More from appointments
Approximately 5 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Life Brands Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics